HomeBBOT • NASDAQ
add
BridgeBio Oncology Therapeutics Inc
Previous close
$12.00
Day range
$11.80 - $12.35
Year range
$8.50 - $13.18
Market cap
945.61M USD
Avg Volume
300.36K
P/E ratio
59.82
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 30.09M | 26.07% |
Net income | 918.31K | 104.21% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -30.02M | -26.05% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 664.23K | -63.39% |
Total assets | 151.25M | -20.34% |
Total liabilities | 29.76M | -84.60% |
Total equity | 121.49M | — |
Shares outstanding | 564.61K | — |
Price to book | -0.03 | — |
Return on assets | -1.47% | — |
Return on capital | -60.16% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 918.31K | 104.21% |
Cash from operations | -298.90K | 96.33% |
Cash from investing | 9.64M | 106.36% |
Cash from financing | 18.96M | -90.50% |
Net change in cash | -298.90K | -100.75% |
Free cash flow | -20.44M | -378,070.68% |
About
Founded
2016
Headquarters
Website
Employees
62
